NCT04924322

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

RecruitingPHASE2, PHASE3INTERVENTIONAL

Trial Details

Start: 2022-05-11Est. Completion: 2027-04-30

Enrollment target: 258 participants

Locations

Children's of Alabama, Birmingham, Alabama, United States
Arkansas Children's Hospital, Little Rock, Arkansas, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Yale-New Haven Children's Hospital, New Haven, Connecticut, United States
University of Florida -UF Health, Gainesville, Florida, United States
Johns Hopkins All Children's, St. Petersburg, Florida, United States
Children's Hospital of Illinois at OSF Saint Francis Medical Center, Peoria, Illinois, United States
Stead Family Children's Hospital, Iowa City, Iowa, United States
Children's Hospital St. Louis, St Louis, Missouri, United States
Hassenfeld Children's Hospital, New York, New York, United States
New York Presbyterian Hospital, New York, New York, United States
Golisano Children's Hospital, Rochester, New York, United States
Maria Fareri Children's Hospital, Valhalla, New York, United States
UH Rainbow Babies & Children's Hospital, Cleveland, Ohio, United States
Nationwide Children's Hospital, Columbus, Ohio, United States

StrokeStroke HemorrhagicIschemic Stroke

Stroke is the leading cause of acquired disability in adults and a major cause of mortality worldwide; in Spain, Andalus…

Seville, SpainEst. completion Mar 31, 2027

Essential Thrombocythemia

The purpose of this study is to evaluate the efficacy and safety of bomedemstat compared with hydroxyurea in cytoreducti…

Glendale, United StatesEst. completion Sep 28, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.